Pharmaceutical - Production, Markets & Marketing

Filter

Popular Filters

1 to 25 of 46 results

Pharma serialization: Is our industry on the brink of a mass extinction event?

Pharma serialization: Is our industry on the brink of a mass extinction event?

18-11-2014

Former AstraZeneca serialization expert, Ian Haynes asks whether the fact that many pharma companies…

Markets & MarketingPharmaceuticalProductionRegulation

ISPE unveils plan to prevent drug shortages

16-10-2014

Regulators from the European Medicines, the US Food and Drug Administration and the UK’s Medicines…

GlobalMarkets & MarketingPharmaceuticalProductionRegulation

Russia to start vaccines supplies to Central and South America

13-10-2014

Russia plans to start active supplies of vaccines to the Central and South America region during the…

Markets & MarketingPharmaceuticalProductionRussiaSouth AmericaVaccines

Boehringer Ingelheim invests 100 million euros to expanded Respimat production, as it's launched in UK

Boehringer Ingelheim invests 100 million euros to expanded Respimat production, as it's launched in UK

01-10-2014

German family-owned pharma major Boehringer Ingelheim is investing more than 100 million euros ($127…

Boehringer IngelheimGermanyMarkets & MarketingPharmaceuticalProductionRespimatRespiratory and PulmonarySpiriva RespimatUK

Strong growth forecast for Saudi Arabia pharmaceuticals market

Strong growth forecast for Saudi Arabia pharmaceuticals market

13-08-2014

Pharmaceuticals products sales in Saudi Arabia are expected to exceed a value of $ 7 billion by 2018,…

Business FinanceFinancialMarkets & MarketingPharmaceuticalProductionRest of the WorldSaudi Arabia

Russia tightens responsibility for sale and production of counterfeit drugs

Russia tightens responsibility for sale and production of counterfeit drugs

30-07-2014

The Russian government has significantly tightened responsibility for the sale and production of counterfeit…

Counterfeit consumer goodsCounterfeit medicationsMarkets & MarketingPharmaceuticalProductionRegulationRussiaRussian government

Ipsen takes step forward in the resupply of Increlex for the USA

Ipsen takes step forward in the resupply of Increlex for the USA

13-05-2014

Following previous availability problems, French drugmaker Ipsen said today that a supply of Increlex…

IncrelexIpsenMarkets & MarketingPharmaceuticalProductionRare diseasesUSA

Marken ready for orphan drug distribution

24-04-2014

USA-based Marken, a global clinical supply chain solutions provider, has released a new white paper which…

Markets & MarketingPharmaceuticalProductionRare diseases

Global Fund taps pharmaceutical expertise in China

02-04-2014

The Global Fund is deepening its partnership with China by tapping the expertise of Chinese pharmaceutical…

Anti-viralsAntibiotics and Infectious diseasesChinaGlobalMarkets & MarketingPharmaceuticalProductionRegulation

China's biopharmaceutical output exceeds 2 trillion renminbi for 2013

China's biopharmaceutical output exceeds 2 trillion renminbi for 2013

27-03-2014

The production value of China's bio-medicine industry amounted to 2.1 trillion renminbi ($338.8 billion)…

Asia-PacificChinaMarkets & MarketingPharmaceuticalProduction

Foreign drug producers continue to dominate in the Russian pharmaceutical market

25-03-2014

Foreign drug producers continue to dominate in the Russian pharmaceutical market, despite the attempts…

Eastern EuropeMarkets & MarketingPharmaceuticalProductionRussia

Progress towards a European Medicines Verification System

04-03-2014

The European Stakeholder Model (ESM) and securPharm eV - a pan European and a German organization, respectively,…

EuropeMarkets & MarketingPharmaceuticalProduction

Brazil to produce atazanavir to supply SUS demand; strong pharma growth forecast for 2014

15-01-2014

Following the Official Gazette market application filling for the drug atazanavir sulfate, an HIV protease…

Anti-viralsatazanavirBrazilBristol-Myers SquibbFiocruzGenericsMarkets & MarketingPharmaceuticalProductionSouth America

Report suggests vertical integration remains popular with pharma distributors in Russia, Ukraine and Kazakhstan

Report suggests vertical integration remains popular with pharma distributors in Russia, Ukraine and Kazakhstan

14-01-2014

Vertical integration among manufacturers, wholesalers and retailers is one of the characteristics of…

Markets & MarketingPharmaceuticalProductionRussiaUkraine

Emerging markets and patent cliffs create supply chain management issues for pharma, white paper warns

Emerging markets and patent cliffs create supply chain management issues for pharma, white paper warns

26-12-2013

A new white paper commissioned by logistics company DHL warns that global life sciences and health care…

BiotechnologyGlobalMarkets & MarketingPharmaceuticalProduction

Ipsen prepares for EU resupply of Increlex; enters deal with Mayoly Spindler

Ipsen prepares for EU resupply of Increlex; enters deal with Mayoly Spindler

18-12-2013

French drugmaker Ipsen says that Lonza has successfully re-manufactured the active ingredient of Increlex…

Anti-Arthritics/RheumaticsEuropeGastro-intestinalsIncrelexIpsenLonzaMarkets & MarketingMayoly SpindlerPharmaceuticalProductionRare diseases

Drug Quality and Security Act passes in US Senate

20-11-2013

After months of discussion in the US Congress, finally HR 3204, the Drug Quality and Security Act, which…

LegalMarkets & MarketingNorth AmericaPharmaceuticalProduction

Sagent Pharma debuts Carboplatin Injection

Sagent Pharma debuts Carboplatin Injection

04-11-2013

US specialty drugmaker Sagent Pharmaceuticals has announced the launch of Carboplatin Injection, an antineoplastic…

Asia-PacificCarboplatinMarkets & MarketingNorth AmericaOncologyPharmaceuticalProductionSagent Pharmaceuticals

Russian pharma market will continue to focus on imports over next few years

27-08-2013

The Russian pharmaceutical market will continue to focus on imports during the next several years, despite…

EuropeMarkets & MarketingPharmaceuticalProduction

Theravance reintroduces Vibativ in USA

14-08-2013

US drug developer Theravance (Nasdaq: THRX) says it has commenced shipments of Vibativ (telavancin) into…

Antibiotics and Infectious diseasesAstellas PharmaMarkets & MarketingNorth AmericaPharmaceuticalProductionTheravanceVibativ

Akrikhin expands deal with Merck & Co

08-08-2013

Leading Russian drugmaker Akrikhin says it has expanded its partnership with US pharma giant Merck &…

Akrikhin PharmaceuticalsCardio-vascularDiabetesEuropeEzetrolJanumetJanuviaMarkets & MarketingMerck & CoNoxafilPharmaceuticalProductionRespiratory and PulmonarySingulair

Analyst's view on Irish pharma export woes

29-07-2013

Following the news that Ireland's pharmaceutical industry has experienced a sharp fall in exports due…

EuropeMarkets & MarketingPatentsPharmaceuticalProduction

Venus gets GMP certifications from Ukraine

22-07-2013

Indian R&D-based drugmaker Venus Remedies (BSE: 526953) has been able to gain a Good Manufacturing Practice…

Antibiotics and Infectious diseasesAsia-PacificEuropeMarkets & MarketingOncologyPharmaceuticalProductionRegulationVenus Remedies

Less than 30% of drugs in Nigeria made locally

15-07-2013

Last week, the Director General, of Nigeria's National Agency for Foods, Drugs Administration and Control,…

GenericsMarkets & MarketingPharmaceuticalProductionRest of the World

1 to 25 of 46 results

Back to top